Brain Tunnelgenix's temperature monitoring system gets FDA nod
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for Brain Tunnelgenix Technologies' Abreu BTT 700, a system for continuous temperature monitoring. It is intended for placement on the skin during surgical procedures, in the recovery room and intensive care unit, and for general patient monitoring. The device measures skin temperature in the region between the eye and the eyebrow, known as the brain temperature tunnel. This fat-free area of skin has the highest level of thermoconductivity in the body, which enables temperature to be accurately and continuously monitored through the skin without losing thermal energy, the Hamden, Connecticut firm claims. The system will be available in the US next month.